|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
General Compression Pulls In $20.4M, Constellation Nabs $15M, PolyRemedy Wraps Up $20M, & More Boston-Area Deals News
|
Erin Kutz |
06/08/11 |
Boston
|
|
Ariad and Infinity to Reveal Data at ASCO, Excelimmune Gets $10.5M, Hologic Buys TCT, & More Boston-Area Life Sciences News
|
Erin Kutz |
06/03/11 |
Boston
|
|
Hologic Buys TCT International
|
Erin Kutz |
06/02/11 |
Boston
|
|
Sanofi Buys Genzyme for $20B, Aveo Inks Deal with Astellas, Hologix Nabs FDA Approval, & More Boston-Area Life Sciences News
|
Erin Kutz |
02/18/11 |
Boston
|
|
Hologic Gets FDA Nod for 3-D Mammography
|
Gregory T. Huang |
02/14/11 |
Boston
|
|
Hologic Buys Interlace for $125M
|
Erin Kutz |
01/07/11 |
Boston
|
|
Helicos Names New CEO
|
Ryan McBride |
10/14/10 |
Boston
|
|
Boston’s Autism Mini-Cluster: New Drugs and Diagnostics Target Mysterious Brain Disorders
|
Ryan McBride |
07/22/10 |
Boston
|
|
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten
|
Luke Timmerman |
10/08/09 |
Boston
|
|
Daktari Diagnostics Closes $2.8M Series A Round to Combat Global HIV Crisis
|
Ryan McBride |
09/04/09 |
Boston
|
|
Biogen Idec Buys MS Drug Rights, Immuneering Models Cancer Drug Responses, Hologic Wins Contraceptive Device Approval, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
07/08/09 |
Boston
|
|
Hologic Device Approved by FDA
|
Rebecca Zacks |
07/07/09 |
Boston
|
|
Mirabilis Medica Aims to Help Women Avoid the Dreaded Hysterectomy
|
Luke Timmerman |
06/22/09 |
Seattle
|
|
New Execs for Exact, Sirtris, and Ischemix; New Deal for Biogen and Aveo; New Money for MedAptus and Claros; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
03/25/09 |
Boston
|
|
After Fending Off Sequenom Takeover, Exact Sciences Replaces CEO and CFO with Diagnostics Vets
|
Ryan McBride |
03/19/09 |
Boston
|
|
Funding Pool Deep for Still River, Cuts in the Offing for Epix and Synta, FDA Approvals Granted for Hologic, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
03/18/09 |
Boston
|
|
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter
|
Luke Timmerman |
03/17/09 |
Boston
|
|
Hologic Gets FDA Nod for HPV Tests
|
Ryan McBride |
03/13/09 |
Boston
|
|
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter
|
Luke Timmerman |
11/25/08 |
Boston
|
|
The Boston-Area Obesity Treatment Cluster: Are Flood Gates Opening for Weight-Loss Drugs and Devices?
|
Ryan McBride |
10/08/08 |
Boston
|
|
Predictive Biosciences Hires New Chiefs for Finance, Medicine
|
Luke Timmerman |
07/16/08 |
Boston
|
|
IRobot Dives into Underwater Robotics, American Superconductor Inks a Supersized Wind Power Deal, BCBSMA Insures Members’ Google Health, & More Deals News
|
Rebecca Zacks |
06/17/08 |
Boston
|
|
Vertex Moves Hepatitis Drug Forward, Merrimack Rakes in $60M, Biogen and Icahn Trade Barbs, & More Life Sciences News
|
Rebecca Zacks |
06/12/08 |
Boston
|
|
Third Wave Means Extra Power For Hologic
|
Erik Mellgren |
06/09/08 |
Boston
|
|
MIT Teams With Italian Energy Giant, Elixir Postpones Its IPO, Biogen Idec Will Buy or Be Bought, & More
|
Rebecca Zacks |
01/23/08 |
Boston
|
|
Hologic Grabs $82M for Drug
|
Rebecca Zacks |
01/22/08 |
Boston
|
|
Hologic Contraceptive Device Gets Nod From FDA Panel
|
Rebecca Zacks |
12/14/07 |
Boston
|
|
$16M for Blackwave, Memsic Sets IPO Range, Hologic Prices $1.5B Worth of Notes, and the Rest of Last Week’s Wheeling and Dealing
|
Rebecca Zacks |
12/10/07 |
Boston
|
|
Shareholders Approve Hologic’s $6.2 Billion Acquisition of Cytyc
|
Malorye Allison |
10/18/07 |
Boston
|
|
Hologic Faces Lawsuit, OLPC Chooses a Distributor, Point Therapeutics Agrees to a Reverse Merger, and More
|
Rebecca Zacks |
10/15/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.